141 related articles for article (PubMed ID: 24857045)
21. Racial disparities in survival among patients with germ cell tumors of the ovary--United States.
Bryant CS; Kumar S; Shah JP; Mahdi H; Ali-Fehmi R; Munkarah AR; Deppe G; Morris RT
Gynecol Oncol; 2009 Sep; 114(3):437-41. PubMed ID: 19560191
[TBL] [Abstract][Full Text] [Related]
22. [Malignant ovarian germ cell tumors. Current status of diagnosis and treatment].
Torres-Lobatón A
Ginecol Obstet Mex; 2014 Mar; 82(3):177-87. PubMed ID: 24779273
[TBL] [Abstract][Full Text] [Related]
23. Site of extranodal metastasis impacts survival in patients with testicular germ cell tumors.
Patel HD; Singla N; Ghandour RA; Freifeld Y; Cheaib JG; Woldu SL; Pierorazio PM; Bagrodia A
Cancer; 2019 Nov; 125(22):3947-3952. PubMed ID: 31355922
[TBL] [Abstract][Full Text] [Related]
24. Prognostic significance of residual disease in advanced stage malignant ovarian germ cell tumors.
Nasioudis D; Chapman-Davis E; Frey MK; Caputo TA; Witkin SS; Holcomb K
Int J Gynecol Cancer; 2019 Mar; 29(3):554-559. PubMed ID: 30700566
[TBL] [Abstract][Full Text] [Related]
25. Surveillance after initial surgery for pediatric and adolescent girls with stage I ovarian germ cell tumors: report from the Children's Oncology Group.
Billmire DF; Cullen JW; Rescorla FJ; Davis M; Schlatter MG; Olson TA; Malogolowkin MH; Pashankar F; Villaluna D; Krailo M; Egler RA; Rodriguez-Galindo C; Frazier AL
J Clin Oncol; 2014 Feb; 32(5):465-70. PubMed ID: 24395845
[TBL] [Abstract][Full Text] [Related]
26. Development and validation of prognostic nomogram for germ cell testicular cancer patients.
Mao W; Wu J; Kong Q; Li J; Xu B; Chen M
Aging (Albany NY); 2020 Nov; 12(21):22095-22111. PubMed ID: 33136554
[TBL] [Abstract][Full Text] [Related]
27. Outcomes of malignant ovarian germ-cell tumors treated in Chiang Mai University Hospital over a nine year period.
Neeyalavira V; Suprasert P
Asian Pac J Cancer Prev; 2014; 15(12):4909-13. PubMed ID: 24998562
[TBL] [Abstract][Full Text] [Related]
28. Clinical management of malignant ovarian germ cell tumors: A 26-year experience in a tertiary care institution.
Hu T; Fang Y; Sun Q; Zhao H; Ma D; Zhu T; Wang C
Surg Oncol; 2019 Dec; 31():8-13. PubMed ID: 31446304
[TBL] [Abstract][Full Text] [Related]
29. Outcomes of Surgery Alone and Surveillance Strategy in Young Women With Stage I Malignant Ovarian Germ Cell Tumors.
Park JY; Kim DY; Suh DS; Kim JH; Kim YM; Kim YT; Nam JH
Int J Gynecol Cancer; 2016 Jun; 26(5):859-64. PubMed ID: 27101582
[TBL] [Abstract][Full Text] [Related]
30. Malignant ovarian germ cell tumors: clinico-pathological presentation and survival outcomes.
Tangjitgamol S; Hanprasertpong J; Manusirivithaya S; Wootipoom V; Thavaramara T; Buhachat R
Acta Obstet Gynecol Scand; 2010; 89(2):182-9. PubMed ID: 19961281
[TBL] [Abstract][Full Text] [Related]
31. Malignant ovarian germ cell tumors in pediatric patients: The AIEOP (Associazione Italiana Ematologia Oncologia Pediatrica) study.
Terenziani M; Bisogno G; Boldrini R; Cecchetto G; Conte M; Boschetti L; De Pasquale MD; Biasoni D; Inserra A; Siracusa F; Basso ME; De Leonardis F; Di Pinto D; Barretta F; Spreafico F; D'Angelo P
Pediatr Blood Cancer; 2017 Nov; 64(11):. PubMed ID: 28449306
[TBL] [Abstract][Full Text] [Related]
32. Fertility-preserving surgery for advanced stage ovarian germ cell tumors.
Nasioudis D; Frey MK; Chapman-Davis E; Caputo TA; Holcomb K
Gynecol Oncol; 2017 Dec; 147(3):493-496. PubMed ID: 29021083
[TBL] [Abstract][Full Text] [Related]
33. The role of staging and adjuvant chemotherapy in stage I malignant ovarian germ cell tumors (MOGTs): the MITO-9 study.
Mangili G; Sigismondi C; Lorusso D; Cormio G; Candiani M; Scarfone G; Mascilini F; Gadducci A; Mosconi AM; Scollo P; Cassani C; Pignata S; Ferrandina G
Ann Oncol; 2017 Feb; 28(2):333-338. PubMed ID: 27803008
[TBL] [Abstract][Full Text] [Related]
34. Need for risk-adapted therapy for malignant ovarian germ cell tumors: A large multicenter analysis of germ cell tumors' patients from French TMRG network.
Derquin F; Floquet A; Hardy-Bessard AC; Edeline J; Lotz JP; Alexandre J; Pautier P; Angeles MA; Delanoy N; Lefeuvre-Plesse C; Cancel M; Treilleux I; Augereau P; Lavoue V; Kalbacher E; Berton Rigaud D; Selle F; Nadeau C; Gantzer J; Joly F; Guillemet C; Pomel C; Favier L; Abdeddaim C; Venat-Bouvet L; Provansal M; Fabbro M; Kaminsky MC; Lortholary A; Lecuru F; Coquard IR; de La Motte Rouge T
Gynecol Oncol; 2020 Sep; 158(3):666-672. PubMed ID: 32624235
[TBL] [Abstract][Full Text] [Related]
35. Adverse prognostic factors for testicular cancer-specific survival: a population-based study of 27,948 patients.
Fosså SD; Cvancarova M; Chen L; Allan AL; Oldenburg J; Peterson DR; Travis LB
J Clin Oncol; 2011 Mar; 29(8):963-70. PubMed ID: 21300926
[TBL] [Abstract][Full Text] [Related]
36. Racial disparities and socioeconomic status in men diagnosed with testicular germ cell tumors: a survival analysis.
Sun M; Abdollah F; Liberman D; Abdo A; Thuret R; Tian Z; Shariat SF; Montorsi F; Perrotte P; Karakiewicz PI
Cancer; 2011 Sep; 117(18):4277-85. PubMed ID: 21387261
[TBL] [Abstract][Full Text] [Related]
37. Fertility and gonadal function after adjuvant therapy in women diagnosed with a malignant ovarian germ cell tumor (MOGCT) during the "cisplatin era".
Solheim O; Tropé CG; Rokkones E; Kærn J; Paulsen T; Salvesen HB; Hagen B; Vereide AB; Fosså SD
Gynecol Oncol; 2015 Feb; 136(2):224-9. PubMed ID: 25511159
[TBL] [Abstract][Full Text] [Related]
38. Second malignant neoplasms after childhood non-central nervous system embryonal tumours in North America: A population-based study.
Zong X; Pole JD; Grundy PE; Mahmud SM; Parker L; Hung RJ
Eur J Cancer; 2017 Oct; 84():173-183. PubMed ID: 28822326
[TBL] [Abstract][Full Text] [Related]
39. Insurance status and disparities in disease presentation, treatment, and outcomes for men with germ cell tumors.
Markt SC; Lago-Hernandez CA; Miller RE; Mahal BA; Bernard B; Albiges L; Frazier LA; Beard CJ; Wright AA; Sweeney CJ
Cancer; 2016 Oct; 122(20):3127-3135. PubMed ID: 27500561
[TBL] [Abstract][Full Text] [Related]
40. Clinical phenotypes and prognostic features of embryonal tumours with multi-layered rosettes: a Rare Brain Tumor Registry study.
Khan S; Solano-Paez P; Suwal T; Lu M; Al-Karmi S; Ho B; Mumal I; Shago M; Hoffman LM; Dodgshun A; Nobusawa S; Tabori U; Bartels U; Ziegler DS; Hansford JR; Ramaswamy V; Hawkins C; Dufour C; André N; Bouffet E; Huang A;
Lancet Child Adolesc Health; 2021 Nov; 5(11):800-813. PubMed ID: 34599879
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]